Chinese Trial Validates Scleral Lenses - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Chinese Trial Validates Scleral Lenses

  • August 28, 2026

  • 3 min

Share

Objective:

To evaluate the effectiveness and safety of a four-zone scleral lens design for visual rehabilitation in Chinese patients with irregular corneas.

Approach:
  • Study Design: A prospective, multi-center clinical trial involving 138 adults aged 18–65 years with irregular corneas across five Chinese centers.
  • Participants: Patients had irregular corneas due to keratoconus, secondary ectasia, corneal transplantation, or corneal scarring.
  • Follow-up: Participants were fitted with scleral lenses and followed for three months, with data collected from 201 treated eyes.
Key Findings:
  • 97.7% of participants achieved successful visual rehabilitation at one month, defined as an improvement of at least 0.20 logMAR compared with spectacle correction.
  • 98.5% of treated eyes gained two or more lines of vision, with a median improvement of 0.30 logMAR.
  • Fitting efficiency was high, with an average of 1.5 lenses per eye needed for optimal fit.
  • By three months, nearly 75% of participants wore lenses for at least eight hours per day.
  • No serious adverse events were reported, and no cases of corneal infection or new corneal neovascularization occurred.
Limitations:
  • The three-month follow-up limits conclusions regarding long-term safety.
  • The absence of a comparator lens group prevents direct comparisons with other specialty lens modalities.
Sources:

Original Source(s)

Related Content